254
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

Adipose-derived stem cells sustain prolonged angiogenesis through leptin secretion

, , , , , , & show all
Pages 87-96 | Received 13 Jan 2016, Accepted 16 May 2016, Published online: 30 Jun 2016

References

  • Bader AM, Klose K, Bieback K, Korinth D, Schneider M, Seifert M, Choi YH, et al. 2015. Hypoxic preconditioning increases survival and pro-angiogenic capacity of human cord blood mesenchymal stromal cells in vitro. PLoS One 10:e0138477.
  • Basciano L, Nemos C, Foliguet B, de Isla N, de Carvalho M, Tran N, Dalloul A. 2011. Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status. BMC Cell Biol 12:12.
  • Bekhite MM, Finkensieper A, Rebhan J, Huse S, Schultze-Mosgau S, Figulla HR, Sauer H, Wartenberg M. 2014. Hypoxia, leptin, and vascular endothelial growth factor stimulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells. Stem Cells Dev 23:333–351.
  • Boguslawski G, McGlynn PW, Harvey KA, Kovala AT. 2004. SU1498, an inhibitor of vascular endothelial growth factor receptor 2, causes accumulation of phosphorylated ERK kinases and inhibits their activity in vivo and in vitro. J Biol Chem 279:5716–5724.
  • Bouloumie A, Drexler HC, Lafontan M, Busse R. 1998. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 83:1059–1066.
  • Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. 2008. Adipose-derived stem cells: Isolation, expansion and differentiation. Methods 45:115–120.
  • Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. 2001. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA 98:6390–6395.
  • Cao Y. 2007. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 117:2362–2368.
  • Casteilla L, Planat-Benard V, Cousin B, Laharrague P, Bourin P. 2010. Vascular and endothelial regeneration. Curr Stem Cell Res Ther 5:141–144.
  • Chang CP, Chio CC, Cheong CU, Chao CM, Cheng BC, Lin MT. 2013. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci (Lond) 124:165–176.
  • Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA. 2009. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 324:1289–1293.
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, et al. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317.
  • Gonzalez-Perez RR, Lanier V, Newman G. 2013. Leptin's pro-angiogenic signature in breast cancer. Cancers (Basel) 5:1140–1162.
  • Goossens GH, Bizzarri A, Venteclef N, Essers Y, Cleutjens JP, Konings E, Jocken JW, et al. 2011. Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation. Circulation 124:67–76.
  • Goossens GH, Blaak EE. 2015. Adipose tissue dysfunction and impaired metabolic health in human obesity: A matter of oxygen? Front Endocrinol (Lausanne) 6:55.
  • Guarani V, Potente M. 2010. SIRT1 – A metabolic sensor that controls blood vessel growth. Curr Opin Pharmacol 10:139–145.
  • Hou J, Chong ZZ, Shang YC, Maiese K. 2010. Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation. Curr Neurovasc Res 7:95–112.
  • Kaelin WG Jr., Ratcliffe PJ. 2008. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell 30:393–402.
  • Kawaji N, Yoshida A, Motoyashiki T, Morita T, Ueki H. 2001. Anti-leptin receptor antibody mimics the stimulation of lipolysis induced by leptin in isolated mouse fat pads. J Lipid Res 42:1671–1677.
  • Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, Heifetz A, Ludlow JW, et al. 2007. Cytokine profile of human adipose-derived stem cells: Expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 212:702–709.
  • Koh MY, Powis G. 2012. Passing the baton: The HIF switch. Trends Biochem Sci 37:364–372.
  • Laemmle A, Lechleiter A, Roh V, Schwarz C, Portmann S, Furer C, Keogh A, et al. 2012. Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions. PLoS One 7:e33433.
  • Lim JH, Lee YM, Chun YS, Chen J, Kim JE, Park JW. 2010. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 38:864–878.
  • Lin RZ, Moreno-Luna R, Zhou B, Pu WT, Melero-Martin JM. 2012. Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Angiogenesis 15:443–455.
  • Maizel J, Xavier S, Chen J, Lin CH, Vasko R, Goligorsky MS. 2014. Sirtuin 1 ablation in endothelial cells is associated with impaired angiogenesis and diastolic dysfunction. Am J Physiol Heart Circ Physiol 307:H1691–H1704.
  • Meissner M, Doll M, Hrgovic I, Reichenbach G, Konig V, Hailemariam-Jahn T, Gille J, Kaufmann R. 2011. Suppression of VEGFR2 expression in human endothelial cells by dimethylfumarate treatment: Evidence for anti-angiogenic action. J Invest Dermatol 131:1356–1364.
  • Ota H, Eto M, Ogawa S, Iijima K, Akishita M, Ouchi Y. 2010. SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J Atheroscler Thromb 17:431–435.
  • Pasarica M, Sereda OR, Redman LM, Albarado DC, Hymel DT, Roan LE, Rood JC, et al. 2009. Reduced adipose tissue oxygenation in human obesity: Evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 58:718–725.
  • Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, O'Donnell CP. 2003. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552:253–264.
  • Potente M, Dimmeler S. 2008. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell Cycle 7:2117–2122.
  • Potente M, Ghaeni L, Baldessari D, Mostoslavsky R, Rossig L, Dequiedt F, Haendeler J, et al. 2007. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev 21:2644–2658.
  • Ramadori G, Lee CE, Bookout AL, Lee S, Williams KW, Anderson J, Elmquist JK, Coppari R. 2008. Brain SIRT1: Anatomical distribution and regulation by energy availability. J Neurosci 28:9989–9996.
  • Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, et al. 2004. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109:1292–1298.
  • Ring BD, Scully S, Davis CR, Baker MB, Cullen MJ, Pelleymounter MA, Danilenko DM. 2000. Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology 141:446–449.
  • Sasaki T, Kim HJ, Kobayashi M, Kitamura YI, Yokota-Hashimoto H, Shiuchi T, Minokoshi Y, Kitamura T. 2010. Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide. Endocrinology 151:2556–2566.
  • Semenza GL. 2012. Hypoxia-inducible factors: Mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33:207–214.
  • Takeda N, Maemura K, Imai Y, Harada T, Kawanami D, Nojiri T, Manabe I, Nagai R. 2004. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1. Circ Res 95:146–153.
  • Tian H, McKnight SL, Russell DW. 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11:72–82.
  • Tobita M, Orbay H, Mizuno H. 2011. Adipose-derived stem cells: Current findings and future perspectives. Discov Med 11:160–170.
  • Valorani MG, Montelatici E, Germani A, Biddle A, D'Alessandro D, Strollo R, Patrizi MP, et al. 2012. Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials. Cell Prolif 45:225–238.
  • Wiesener MS, Jurgensen JS, Rosenberger C, Scholze CK, Horstrup JH, Warnecke C, Mandriota S, et al. 2003. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 17:271–273.
  • Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, Wood SM, et al. 1998. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92:2260–2268.
  • Ye J, Gao Z, Yin J, He Q. 2007. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293:E1118–E1128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.